Squarepoint’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-76,400
Closed -$8.69M 4020
2022
Q4
$8.69M Buy
+76,400
New +$6.35M 0.03% 566

Other funds holding HZNP

Squarepoint's HZNP Position: Q3 2023 in Review

Squarepoint sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2023, closing a stake of 93,928 shares — an estimated $10.1M sold.

Squarepoint first reported a position in HZNP in Q2 2015 and held it in 26 quarters. The position peaked at $24.9M in Q4 2021. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.

  • Squarepoint reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • Squarepoint sold 93,928 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2023, an estimated $10.1M.
  • Squarepoint first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and held it in 26 quarters.
  • Squarepoint's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $24.9M in Q4 2021.
  • 485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.

Based on Squarepoint's 13F filing for Q3 2023, filed 14 Nov 2023.